AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) partner on one of the biggest cancer drugs in the world. At the same time, the two pharmaceutical companies compete tooth-and-nail against each other in the immunology market. J&J has been the bigger winner so far in 2019 eve...

The stock market has been volatile and wild during the year thus far. Also, stocks have gone nowhere compared to a year earlier. In the last year, we had many instances of panics and decline. However, each time the major indexes quickly recovered. The SPDR S&P 500 Index ETF (NYSEARCA: SPY ...

Quick Take IGM Biosciences ( IGMS ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is focused on the development of engineered IgM antibodies as cancer treatments. IGMS is a very early stage firm seeking public ca...